tocriscreen library Search Results


93
Bio-Techne corporation tocriscreen gpcr compound library
Tocriscreen Gpcr Compound Library, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tocriscreen gpcr compound library/product/Bio-Techne corporation
Average 93 stars, based on 1 article reviews
tocriscreen gpcr compound library - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

95
Tocris 2025 tocriscreen fda approved drugs library
2025 Tocriscreen Fda Approved Drugs Library, supplied by Tocris, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2025 tocriscreen fda approved drugs library/product/Tocris
Average 95 stars, based on 1 article reviews
2025 tocriscreen fda approved drugs library - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

93
Tocris kinase inhibitors
Fig. 1. Schematic illustration of the 80 kinase inhibitor screen. Three kinase <t>inhibitors</t> (KIs) were tested per 12-well plate. For each plate, 60 Hydra gastric regions were isolated by removing the head and foot. For each treatment, 15 gastric regions were rinsed with the respective solution (KI #1, KI #2, KI #3, or control) before dividing them into 3 wells (5 gastric regions per well) containing the respective exposure solutions. Control replicates were exposed to 1% DMSO alone and included on every plate.
Kinase Inhibitors, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kinase inhibitors/product/Tocris
Average 93 stars, based on 1 article reviews
kinase inhibitors - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Tocris dnmt2 pilot screening
A MST traces of the <t>DNMT2</t> enzyme reaction (250 nM DNMT2, 5 µM tRNA, 0.9 µM SAM) incubated for variable durations (0–120 min) and yielded significant thermophoresis shifts. B Substrate conversion plots (F norm vs incubation time) reveal steady-state DNMT2 kinetics. C Dose-response curves of aptaSAH1&2 (both 50 nM) in the presence of SHO108/SH112 inhibitors (0–100 µM) indicated these SAH-analogs are not binding to the aptamer at relevant concentrations. D – F Inhibitor characterization of SHO108 from left to right: MST traces at variable inhibitor concentrations; MST-derived dose-response curves; orthogonal 3 H-incorporation assay-derived dose-response curves from detected counts per minute (CPMA). G – I Inhibitor characterization of SH112 analogous to subplot ( D – F ). All inhibitor characterizations were performed in triplicates (mean ± SD, n = 3).
Dnmt2 Pilot Screening, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dnmt2 pilot screening/product/Tocris
Average 93 stars, based on 1 article reviews
dnmt2 pilot screening - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

92
Tocris tocriscreen 2 0 micro library
A MST traces of the <t>DNMT2</t> enzyme reaction (250 nM DNMT2, 5 µM tRNA, 0.9 µM SAM) incubated for variable durations (0–120 min) and yielded significant thermophoresis shifts. B Substrate conversion plots (F norm vs incubation time) reveal steady-state DNMT2 kinetics. C Dose-response curves of aptaSAH1&2 (both 50 nM) in the presence of SHO108/SH112 inhibitors (0–100 µM) indicated these SAH-analogs are not binding to the aptamer at relevant concentrations. D – F Inhibitor characterization of SHO108 from left to right: MST traces at variable inhibitor concentrations; MST-derived dose-response curves; orthogonal 3 H-incorporation assay-derived dose-response curves from detected counts per minute (CPMA). G – I Inhibitor characterization of SH112 analogous to subplot ( D – F ). All inhibitor characterizations were performed in triplicates (mean ± SD, n = 3).
Tocriscreen 2 0 Micro Library, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tocriscreen 2 0 micro library/product/Tocris
Average 92 stars, based on 1 article reviews
tocriscreen 2 0 micro library - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

93
Tocris tocriscreen stem cell toolbox
KEY RESOURCES TABLE
Tocriscreen Stem Cell Toolbox, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tocriscreen stem cell toolbox/product/Tocris
Average 93 stars, based on 1 article reviews
tocriscreen stem cell toolbox - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Tocris antiviral library
KEY RESOURCES TABLE
Antiviral Library, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antiviral library/product/Tocris
Average 93 stars, based on 1 article reviews
antiviral library - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Tocris gpcr compound libraries
KEY RESOURCES TABLE
Gpcr Compound Libraries, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gpcr compound libraries/product/Tocris
Average 93 stars, based on 1 article reviews
gpcr compound libraries - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Bio-Techne corporation tocriscreen fda-approved drugs library
KEY RESOURCES TABLE
Tocriscreen Fda Approved Drugs Library, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tocriscreen fda-approved drugs library/product/Bio-Techne corporation
Average 93 stars, based on 1 article reviews
tocriscreen fda-approved drugs library - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Bio-Techne corporation tocriscreen stem cell library
KEY RESOURCES TABLE
Tocriscreen Stem Cell Library, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tocriscreen stem cell library/product/Bio-Techne corporation
Average 93 stars, based on 1 article reviews
tocriscreen stem cell library - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Bio-Techne corporation tocriscreen antiviral library
KEY RESOURCES TABLE
Tocriscreen Antiviral Library, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tocriscreen antiviral library/product/Bio-Techne corporation
Average 90 stars, based on 1 article reviews
tocriscreen antiviral library - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. Schematic illustration of the 80 kinase inhibitor screen. Three kinase inhibitors (KIs) were tested per 12-well plate. For each plate, 60 Hydra gastric regions were isolated by removing the head and foot. For each treatment, 15 gastric regions were rinsed with the respective solution (KI #1, KI #2, KI #3, or control) before dividing them into 3 wells (5 gastric regions per well) containing the respective exposure solutions. Control replicates were exposed to 1% DMSO alone and included on every plate.

Journal: The International journal of developmental biology

Article Title: A screen of kinase inhibitors reveals a potential role of Chk1 in regulating Hydra head regeneration and maintenance.

doi: 10.1387/ijdb.210087yl

Figure Lengend Snippet: Fig. 1. Schematic illustration of the 80 kinase inhibitor screen. Three kinase inhibitors (KIs) were tested per 12-well plate. For each plate, 60 Hydra gastric regions were isolated by removing the head and foot. For each treatment, 15 gastric regions were rinsed with the respective solution (KI #1, KI #2, KI #3, or control) before dividing them into 3 wells (5 gastric regions per well) containing the respective exposure solutions. Control replicates were exposed to 1% DMSO alone and included on every plate.

Article Snippet: The use of kinase inhibitors to identify potential novel regulators of Hydra regeneration To identify novel signaling pathways underlying Hydra regeneration, an unbiased screen of 80 kinase inhibitors (Tocriscreen Kinase Inhibitor Toolbox Cat. No. 3514) was performed.

Techniques: Isolation, Control

Fig. 2. Morphological categorization following exposure to the 80 kinase inhibitors. In total, 4 major morphologies were observed in Hydra following exposure to the 80 kinase inhibitors: (A) complete regeneration, (B) partial regeneration – the presence of shortened tentacles and/or body column, (C) arrested regeneration - no formation of a head and foot, and (D) disintegration - the breakdown of tissues into debris. Scale bar in (A) represents 1000 mm and applies to all panels.

Journal: The International journal of developmental biology

Article Title: A screen of kinase inhibitors reveals a potential role of Chk1 in regulating Hydra head regeneration and maintenance.

doi: 10.1387/ijdb.210087yl

Figure Lengend Snippet: Fig. 2. Morphological categorization following exposure to the 80 kinase inhibitors. In total, 4 major morphologies were observed in Hydra following exposure to the 80 kinase inhibitors: (A) complete regeneration, (B) partial regeneration – the presence of shortened tentacles and/or body column, (C) arrested regeneration - no formation of a head and foot, and (D) disintegration - the breakdown of tissues into debris. Scale bar in (A) represents 1000 mm and applies to all panels.

Article Snippet: The use of kinase inhibitors to identify potential novel regulators of Hydra regeneration To identify novel signaling pathways underlying Hydra regeneration, an unbiased screen of 80 kinase inhibitors (Tocriscreen Kinase Inhibitor Toolbox Cat. No. 3514) was performed.

Techniques:

Fig. 3. Drug Exposure Impact of the 80 kinase inhibitors on Hydra regeneration. Kinase inhibitors were grouped by the main signal transduction pathways they are presumed to target. Drug Exposure Impact (DEI) values on regeneration were calculated as the difference in regeneration scores obtained for control and Hydra exposed to 5 mM kinase inhibitor. DEI values for complete regeneration ranged between -1.07 and 1.2; partial regen eration ranged between -4.4 and 0.6; arrested regeneration ranged between -7.67 and -4; and disintegration ranged between -10 and -7.8. Error bars represent ± 2x standard error.

Journal: The International journal of developmental biology

Article Title: A screen of kinase inhibitors reveals a potential role of Chk1 in regulating Hydra head regeneration and maintenance.

doi: 10.1387/ijdb.210087yl

Figure Lengend Snippet: Fig. 3. Drug Exposure Impact of the 80 kinase inhibitors on Hydra regeneration. Kinase inhibitors were grouped by the main signal transduction pathways they are presumed to target. Drug Exposure Impact (DEI) values on regeneration were calculated as the difference in regeneration scores obtained for control and Hydra exposed to 5 mM kinase inhibitor. DEI values for complete regeneration ranged between -1.07 and 1.2; partial regen eration ranged between -4.4 and 0.6; arrested regeneration ranged between -7.67 and -4; and disintegration ranged between -10 and -7.8. Error bars represent ± 2x standard error.

Article Snippet: The use of kinase inhibitors to identify potential novel regulators of Hydra regeneration To identify novel signaling pathways underlying Hydra regeneration, an unbiased screen of 80 kinase inhibitors (Tocriscreen Kinase Inhibitor Toolbox Cat. No. 3514) was performed.

Techniques: Transduction, Control

A MST traces of the DNMT2 enzyme reaction (250 nM DNMT2, 5 µM tRNA, 0.9 µM SAM) incubated for variable durations (0–120 min) and yielded significant thermophoresis shifts. B Substrate conversion plots (F norm vs incubation time) reveal steady-state DNMT2 kinetics. C Dose-response curves of aptaSAH1&2 (both 50 nM) in the presence of SHO108/SH112 inhibitors (0–100 µM) indicated these SAH-analogs are not binding to the aptamer at relevant concentrations. D – F Inhibitor characterization of SHO108 from left to right: MST traces at variable inhibitor concentrations; MST-derived dose-response curves; orthogonal 3 H-incorporation assay-derived dose-response curves from detected counts per minute (CPMA). G – I Inhibitor characterization of SH112 analogous to subplot ( D – F ). All inhibitor characterizations were performed in triplicates (mean ± SD, n = 3).

Journal: Communications Chemistry

Article Title: A microscale thermophoresis-based enzymatic RNA methyltransferase assay enables the discovery of DNMT2 inhibitors

doi: 10.1038/s42004-025-01439-9

Figure Lengend Snippet: A MST traces of the DNMT2 enzyme reaction (250 nM DNMT2, 5 µM tRNA, 0.9 µM SAM) incubated for variable durations (0–120 min) and yielded significant thermophoresis shifts. B Substrate conversion plots (F norm vs incubation time) reveal steady-state DNMT2 kinetics. C Dose-response curves of aptaSAH1&2 (both 50 nM) in the presence of SHO108/SH112 inhibitors (0–100 µM) indicated these SAH-analogs are not binding to the aptamer at relevant concentrations. D – F Inhibitor characterization of SHO108 from left to right: MST traces at variable inhibitor concentrations; MST-derived dose-response curves; orthogonal 3 H-incorporation assay-derived dose-response curves from detected counts per minute (CPMA). G – I Inhibitor characterization of SH112 analogous to subplot ( D – F ). All inhibitor characterizations were performed in triplicates (mean ± SD, n = 3).

Article Snippet: A compound library for the DNMT2 pilot screening (including Cpd 1–10 ) was commercially obtained (Tocriscreen Epigenetics 3.0, Cat. No. 7578).

Techniques: Incubation, Binding Assay, Derivative Assay

A Screening a library including 160 drug-like compounds resulted in the identification of ten potential hit compounds (green) with an F norm > 1000‰ (equals >80% inhibition). Initial hits were confirmed by triplicate validation (mean ± SD, n = 3). Positive reaction control: aptamer spiked with 1 µM SAH; negative control: aptamer mock-treated with DMSO. B Exemplary MST traces of the library’s first 80 compounds. C Orthogonal screening of the library by FP displacement experiments using FTAD as the fluorescent tracer. FP experiments reveal that only alexidine ( Cpd 3 , green) is binding to the SAH-binding site. D An inhibition selectivity panel was established by MST aptamer assays using the MTase assays described in this study and 500 µM of the respective hit compound. Only DNMT2 was inhibited significantly. E Alexidine’s ( Cpd 3 ) dose-response curves and K D determination by DNMT2 FP assays (mean ± SD, n = 3). F FP assays to confirm the reversibility of alexidine binding to DNMT2. The polarization of the DNMT2-FTAD complex (96 mP) is displaced in the presence of alexidine (5 mP) and can be effectively restored by analytical size-exclusion chromatography (92 mP). A second treatment with alexidine leads to a repeated FP displacement (4 mP). G Chemical structures of the identified DNMT2 hits.

Journal: Communications Chemistry

Article Title: A microscale thermophoresis-based enzymatic RNA methyltransferase assay enables the discovery of DNMT2 inhibitors

doi: 10.1038/s42004-025-01439-9

Figure Lengend Snippet: A Screening a library including 160 drug-like compounds resulted in the identification of ten potential hit compounds (green) with an F norm > 1000‰ (equals >80% inhibition). Initial hits were confirmed by triplicate validation (mean ± SD, n = 3). Positive reaction control: aptamer spiked with 1 µM SAH; negative control: aptamer mock-treated with DMSO. B Exemplary MST traces of the library’s first 80 compounds. C Orthogonal screening of the library by FP displacement experiments using FTAD as the fluorescent tracer. FP experiments reveal that only alexidine ( Cpd 3 , green) is binding to the SAH-binding site. D An inhibition selectivity panel was established by MST aptamer assays using the MTase assays described in this study and 500 µM of the respective hit compound. Only DNMT2 was inhibited significantly. E Alexidine’s ( Cpd 3 ) dose-response curves and K D determination by DNMT2 FP assays (mean ± SD, n = 3). F FP assays to confirm the reversibility of alexidine binding to DNMT2. The polarization of the DNMT2-FTAD complex (96 mP) is displaced in the presence of alexidine (5 mP) and can be effectively restored by analytical size-exclusion chromatography (92 mP). A second treatment with alexidine leads to a repeated FP displacement (4 mP). G Chemical structures of the identified DNMT2 hits.

Article Snippet: A compound library for the DNMT2 pilot screening (including Cpd 1–10 ) was commercially obtained (Tocriscreen Epigenetics 3.0, Cat. No. 7578).

Techniques: Inhibition, Biomarker Discovery, Control, Negative Control, Binding Assay, Size-exclusion Chromatography

A Screening a library including 80 cysteine-focused covalent compounds resulted in the identification of one single hit compound (green) with an F norm > 1000‰ (equals >90% inhibition). Initial hits were confirmed by triplicate validation (mean ± SD, n = 3). Positive reaction control: aptamer spiked with 1 µM SAH; negative control: aptamer mock treated with DMSO. B Orthogonal screening of the library by fluorescence polarization displacement experiments using FTAD as the fluorescent tracer. FP experiments reveal that only adamantanyl-acryloylurea ( Cpd 11 , green) is binding to the SAH-binding site. C MST-derived dose-response curve for adamantanyl-acryloylurea ( Cpd 11 ) including the chemical structure. All inhibitor characterizations were performed in triplicates (mean ± SD, n = 3). D FP assay with Cpd 11 showing time-dependent DNMT2 inhibition with hyperbolic FP displacement plots. E Covalent dose-response analysis of subfigure D: k obs vs. [I] for the determination of covalent inhibition constants ( K I , k inact ) , .

Journal: Communications Chemistry

Article Title: A microscale thermophoresis-based enzymatic RNA methyltransferase assay enables the discovery of DNMT2 inhibitors

doi: 10.1038/s42004-025-01439-9

Figure Lengend Snippet: A Screening a library including 80 cysteine-focused covalent compounds resulted in the identification of one single hit compound (green) with an F norm > 1000‰ (equals >90% inhibition). Initial hits were confirmed by triplicate validation (mean ± SD, n = 3). Positive reaction control: aptamer spiked with 1 µM SAH; negative control: aptamer mock treated with DMSO. B Orthogonal screening of the library by fluorescence polarization displacement experiments using FTAD as the fluorescent tracer. FP experiments reveal that only adamantanyl-acryloylurea ( Cpd 11 , green) is binding to the SAH-binding site. C MST-derived dose-response curve for adamantanyl-acryloylurea ( Cpd 11 ) including the chemical structure. All inhibitor characterizations were performed in triplicates (mean ± SD, n = 3). D FP assay with Cpd 11 showing time-dependent DNMT2 inhibition with hyperbolic FP displacement plots. E Covalent dose-response analysis of subfigure D: k obs vs. [I] for the determination of covalent inhibition constants ( K I , k inact ) , .

Article Snippet: A compound library for the DNMT2 pilot screening (including Cpd 1–10 ) was commercially obtained (Tocriscreen Epigenetics 3.0, Cat. No. 7578).

Techniques: Inhibition, Biomarker Discovery, Control, Negative Control, Fluorescence, Binding Assay, Derivative Assay, FP Assay

KEY RESOURCES TABLE

Journal: Cell reports

Article Title: Long-Term In Vitro Expansion of Epithelial Stem Cells Enabled by Pharmacological Inhibition of PAK1-ROCK-Myosin II and TGF-β Signaling

doi: 10.1016/j.celrep.2018.09.072

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Tocriscreen Stem Cell Toolbox , Tocris , Cat# 5060.

Techniques: Virus, Selection, Recombinant, Real-time Polymerase Chain Reaction, Sequencing, Paraffin Section, Staining, Enzyme-linked Immunosorbent Assay, In Vivo, Methylated DNA Immunoprecipitation Sequencing, Cell Culture, Software, DNA Methylation Assay